MDT
NYSE · Health Care
Medtronic Plc
$78.81
-2.12 (-2.62%)
Financial Highlights (FY 2026)
Revenue
35.84B
Net Income
4.73B
Gross Margin
65.3%
Profit Margin
13.2%
Rev Growth
+5.2%
D/E Ratio
0.57
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 65.3% | 65.3% | 65.6% | 65.6% |
| Operating Margin | 17.8% | 16.0% | 18.7% | 15.7% |
| Profit Margin | 13.2% | 12.5% | 13.2% | 12.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 35.84B | 34.07B | 38.01B | 39.84B |
| Gross Profit | 23.41B | 22.25B | 24.94B | 26.14B |
| Operating Income | 6.37B | 5.45B | 7.11B | 6.27B |
| Net Income | 4.73B | 4.05B | 5.01B | 5.11B |
| Gross Margin | 65.3% | 65.3% | 65.6% | 65.6% |
| Operating Margin | 17.8% | 16.0% | 18.7% | 15.7% |
| Profit Margin | 13.2% | 12.5% | 13.2% | 12.8% |
| Rev Growth | +5.2% | +5.2% | +7.6% | +8.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 18.57B | 18.57B | 46.06B | 47.08B |
| Total Equity | 32.84B | 32.84B | 64.44B | 73.11B |
| D/E Ratio | 0.57 | 0.57 | 0.71 | 0.64 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 8.12B | 7.33B | 10.33B | 9.57B |
| Free Cash Flow | — | — | 5.93B | 5.01B |